Healthcare Businesses for Sale and Investment in Hyderabad

Pharmaceutical API manufacturing company serving both pharmaceutical and cosmetic industries with specialized product offerings. - Produces APIs used in anti-depressants, anti-allergy, oncology, and pain management drugs, along with UV filters for skincare and sunscreen applications. - Operates in a niche segment with a focused client base of 5–6 active customers, ensuring repeat business and stable relationships. - Led by a promoter with over two decades of industry experience, bringing strong technical and regulatory expertise. - Fully compliant with industry standards, holding API test license, drug license, and environmental clearance. - Equipped with an 80,000-litre production capacity plant, currently running at 60–70% utilization, offering clear headroom for scale. - Workforce of 45 employees managing production, quality, and operations. - Revenue is driven by high-value B2B API manufacturing, where automated processes and bulk production enable strong output with a lean workforce. - Run rate sales have declined due to working capital constraints limiting production capacity and order fulfillment. - The company is not an USFDA approved company.

Pharmaceutical API manufacturing company serving both pharmaceutical and cosmetic industries with specialized product offerings. - Produces APIs used in anti-depressants, anti-allergy, oncology, and pain management drugs, along with UV filters for skincare and sunscreen applications. - Operates in a niche segment with a focused client base of 5–6 active customers, ensuring repeat business and stable relationships. - Led by a promoter with over two decades of industry experience, bringing strong technical and regulatory expertise. - Fully compliant with industry standards, holding API test license, drug license, and environmental clearance. - Equipped with an 80,000-litre production capacity plant, currently running at 60–70% utilization, offering clear headroom for scale. - Workforce of 45 employees managing production, quality, and operations. - Revenue is driven by high-value B2B API manufacturing, where automated processes and bulk production enable strong output with a lean workforce. - Run rate sales have declined due to working capital constraints limiting production capacity and order fulfillment. - The company is not an USFDA approved company.

• Manufacturer and exporter of homeopathic OTC products, offering a wide portfolio including single remedy pills, dilutions, tablets, pellets, family kits, and blank sugar globules. • Operates as a digitally native, direct-to-consumer (D2C) brand with sales infrastructure built for its own website and major US marketplaces such as Amazon, eBay, and Walmart. • Holds a rare multinational structure with legal entities in the United States, India, and Canada, enabling global operations and regulatory alignment. • Manufacturing facility in India is US FDA registered and has undergone multiple inspections, with only minor observations in the latest review and clearance expected to resume exports. • Owns a US FDA Drug Master File (Type IV) for homeopathic blank pellets, positioning the business as a qualified global supplier of pharmaceutical-grade excipients. • Portfolio includes thousands of OTC SKUs listed with the US FDA, reflecting significant product depth and regulatory groundwork. • Brand is a registered trademark in the United States, strengthening intellectual property protection and market positioning. • Demonstrates strong customer validation through high ratings across major marketplaces and its own platform, indicating product acceptance despite pre-revenue status. • US-based fulfillment center is FDA-inspected with no observations, capable of handling large-scale order volumes and compliant with cGMP standards including recalls and complaint handling. • Backed by a founding team with decades of domain experience in homeopathy and established industry presence. • Built a scalable proprietary e-commerce infrastructure integrated with production systems and third-party platforms, ready to support high SKU and order volumes. • Currently pre-revenue with no sales recorded yet from the India facility; regulatory processes including US FDA inspection are in progress.

Operates a unisex fitness brand with two large-format gym outlets under a sole proprietorship structure. - Serves a combined base of over 700 active members across both locations, reflecting strong local traction. - One outlet operates under a Cult. fit franchise, while the second outlet is independently run. - The Cult. fit–affiliated gym contributes higher revenue due to brand-led demand and structured programs. - Offers a wide range of fitness services including gym workouts, boxing, personal training, yoga, Zumba, and steam bath facilities. - Each outlet spans approximately 6,000 sq. ft. and operates from leased premises.

New pharmaceutical marketing company based in Hyderabad, and established in August last year. - Offers over 10 proprietary products under its own brand, covering various segments of the pharmaceutical industry. - Manufacturing is outsourced to reputable partners, ensuring quality while focusing on branding and formulation in-house. - Serves approximately 60 clients across Hyderabad, with plans to expand the client network and increase market reach. - Expected to generate yearly sales of INR 55 lakh by next year, with an emphasis on year-over-year sales growth. - Actively seeking investment to enhance marketing efforts, expand the product line, and ensure faster growth in a competitive pharmaceutical market.